Paul Schimmel, Ph.d.
co-founding director
Biotechnology
KinDex?Pharmaceuticals Inc
United States of America
Biography
Dr. Schimmel is the Ernest and Jean Hahn Professor at the Skaggs Institute for Chemical Biology at the Scripps Research Institute. He was previously a Professor of Biochemistry and Biophysics in the Department of Biology at MIT. Dr. Schimmel is co-author of more than 450 publications and a textbook on biophysical chemistry, is the holder of several patents and is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, the American Philosophical Society, and the Institute of Medicine. Dr. Schimmel is a co-founder or co-founding director of several biotechnology companies, including Alkermes, Alnylam Pharmaceuticals, Sirtris Pharmaceuticals, Cubist Pharmaceuticals, Momenta Pharmaceuticals and Repligen.
Research Interest
He is interested in Biophysical chemistry
